Pyrazolo-3,4-B pyridinforbindelser og deres anvendelse som phosphodiesterase inhibitorer

The invention relates to a compound of formula (I) or a salt thereof: wherein: R1 is C1-4alkyl, C1-3fluoroalkyl or -(CH2)2OH; R2 is a hydrogen atom (H), methyl or C1fluoroalkyl; R3a is a hydrogen atom (H) or C1-3alkyl; R3 is optionally substituted branched C3-6alkyl, optionally substituted C3-8cyclo...

Full description

Saved in:
Bibliographic Details
Main Authors COOK, CAROLINE MARY, ALLEN, DAVID GEORGE, COOPER, ANTHONY WILLIAM JAMES, HAMBLIN, JULIE NICOLE, JOHNSON, MARTIN, REDPATH, LINDVALL, MIKA, KRISTIAN, MITCHELL, CHARLOTTE, JANE, EDLIN, CHRISTOPHER, DAVID, COE, DIANE MARY, DOWLE, MICHAEL DENNIS, REDGRAVE, ALISON, JUDITH, JONES, PAUL SPENCER
Format Patent
LanguageDanish
Published 16.08.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to a compound of formula (I) or a salt thereof: wherein: R1 is C1-4alkyl, C1-3fluoroalkyl or -(CH2)2OH; R2 is a hydrogen atom (H), methyl or C1fluoroalkyl; R3a is a hydrogen atom (H) or C1-3alkyl; R3 is optionally substituted branched C3-6alkyl, optionally substituted C3-8cycloalkyl, optionally substituted mono-unsaturated-C5-7cycloalkenyl, optionally substituted phenyl, or an optionally substituted heterocyclic group of sub-formula (aa), (bb) or (cc): in which n1 and n2 independently are 1 or 2; and Y is O, S, SO2, or NR4; and wherein Het is of sub-formula (i), (ii), (iii), (iv) or (v): The compounds are phosphodiesterase (PDE) inhibitors, in particular PDE4 inhibitors. Also provided is the use of a compound of formula (I), or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment and/or prophylaxis of an inflammatory and/or allergic disease in a mammal such as a human, for example chronic obstructive pulmonary disease (COPD), asthma, or allergic rhinitis.
Bibliography:Application Number: DK20030789413T